Ravelcare limited IPO Overview
Ravelcare limited IPO is a SME public issue offered through a Book Building issue with a total issue size of ₹24.10 Cr. The IPO price band is set at ₹123 to ₹130 per share, and retail investors can apply with a minimum investment of ₹2.60 L as per IPO guidelines.
The Ravelcare limited IPO opens on 1 Dec 2025 and closes on 3 Dec 2025. The IPO allotment is expected to be finalized on 4 Dec 2025, and the equity shares are proposed to be listed on BSE on 8 Dec 2025.
Investors can refer to the Ravelcare limited IPO RHP-DRHP for detailed information. The issue is managed by Marwadi Ch,arana Intermediaries Brokers Pvt.Ltd. as the book running lead manager, while Kfin Technologies Limited is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About ravelcare limited
The company operates primarily through its website and online marketplaces such as Amazon, Flipkart, and Myntra, along with quick commerce platforms like Blinkit. In FY 2024–25, Ravelcare expanded its presence internationally, catering to customers in the UAE, Australia, Canada, Germany, the USA, and Saudi Arabia.
To ensure supply chain reliability and timely product delivery, the company manages logistics and warehousing operations across central Indian states. Additionally, Ravelcare plans to set up its integrated manufacturing facility in Mauje-Peth, Amravati, Maharashtra, with a proposed installed capacity of 1,050 TPA. This facility will house R&D, manufacturing, packaging, warehousing, and distribution under one roof.
Product Offerings
Ravelcare’s portfolio spans four key segments:
Haircare: Includes shampoos, conditioners, masks, oils, and styling products tailored to concerns like hair fall, frizz, and damage from chemical treatments. Products are customized via digital consultations and are sold through online platforms.
Skincare comprises cleansers, serums, moisturisers, sunscreens, and treatments for acne, dryness, pigmentation, and sensitivity. Customisation is based on digital skin assessments.
Bodycare: Offers body washes and lotions designed for hydration, cleansing, and skin barrier repair, addressing conditions like dryness and sensitivity.
Scalp Care: Features targeted treatments such as anti-dandruff tonics, hair growth serums, and approved hair fall control ampoules for issues like dryness, flaking, and buildup.
As of June 30, 2025, the company employed 25 professionals across departments.
Competitive Strengths
Wide and Diversified Customer Base: The company serves a broad domestic and international customer base through a distributed warehousing model and third-party logistics, ensuring fast and reliable delivery.
Digital-First Distribution: Operating primarily through D2C channels, Ravelcare reduces dependency on intermediaries and controls the entire customer journey—from discovery to delivery—allowing competitive pricing and consistent service.
Customer-Centric Approach: Ravelcare builds strong relationships via a personalised digital consultation process, enabling the brand to understand individual needs and provide tailored product recommendations. Word-of-mouth from satisfied customers drives organic growth.
Innovation-Led Product Development: The company continuously innovates based on customer feedback and digital interactions. Product development includes concept ideation, formulation, regulatory compliance, testing, and market positioning, driven by structured consumer insights.
With its focus on personalisation, international expansion, and digital innovation, Ravelcare Ltd. positions itself as a modern, data-driven beauty and personal care brand addressing the evolving needs of customers globally.
Investment Objective
Setting up a new manufacturing facility located at Mauje-Peth in Amravati (“Proposed facility”)
General Corporate Purposes
